Clinical Trial Update: Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating the efficacy and safety of a 5% lidocaine patch versus placebo for herpes zoster-associated pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Lidocaine patch 5% (Lidocaine)

Snippet

Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd | Conditions: Herpes Zoster Pain | Phase 2, Phase 3 | Status: COMPLETED